MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc ...

Investing.com - Fortress Biotech (NASDAQ:FBIO), whose shares have declined over 31% in the past week and currently trade at $2.56, received mixed news Wednesday as the company announced a regulatory ...

For the uninitiated, the world of investing can feel a little bit like alphabet soup. One of the many acronyms you’ll need to familiarize yourself with as you dip your toe into things is ETF. Short ...

We’ve all heard the phrase "make your money work for you," but what does it actually mean? It’s not about putting your cash under a mattress or letting it sit in a savings account. It’s about putting ...

Taiwan Semiconductor Manufacturing Co. is a major supplier for leading chip companies such as Nvidia, Advanced Micro Devices and Broadcom. While TSMC’s second-quarter revenue grew 44% year over year, ...

Oracle is laying off more workers in Washington state. The cloud and database giant is laying off 101 employees in Seattle, according to a new filing with the Washington state Employment Security ...

Learn beginner-friendly investing strategies for personal finance and retirement. Budget Girl shares insights on how to start investing, even from zero! Nigel Farage warns Americans traveling to UK ...

Why does the smart money keep flunking Investing 101? During the 2008-09 global financial crisis, many of the world’s biggest investors found themselves in dire need of cash because they had sunk too ...

In 2023, InvestiFi helped WeStreet Credit Union and Frankenmuth Credit Union offer crypto investing services to members. "At the time, most credit unions weren't willing to jump into the market," says ...

Ashely Claudino is an Evergreen Staff Writer from Portugal. She has a Translation degree from the University of Lisbon (2020, Faculty of Arts and Humanities). Nowadays, she mostly writes Fortnite and ...

Viking Therapeutics has key weight loss drugs in phase 2 and phase 3 trials. The race is on to bring an oral formulation weight loss medication to market, and Novo Nordisk appears to be the leader.